These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29050449)

  • 1. Doubling golimumab doses did not improve skin disease in two obese patients with psoriatic arthritis.
    Bonifati C; Lora V; Graceffa D
    G Ital Dermatol Venereol; 2017 Dec; 152(6):670-672. PubMed ID: 29050449
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensification therapy with golimumab: a new treatment strategy for moderate-severe refractory psoriasis.
    Torregrosa Calatayud JL; Garcías Ladaria J; Sánchez Carazo JL; Pérez-Ferriols A; Oliver Martínez V; Calvo Catalá J; Alegre de Miquel V
    Int J Dermatol; 2014 Dec; 53(12):e585-7. PubMed ID: 25312905
    [No Abstract]   [Full Text] [Related]  

  • 3. Golimumab: in the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Oldfield V; Plosker GL
    BioDrugs; 2009; 23(2):125-35. PubMed ID: 19489653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study.
    Kavanaugh A; McInnes I; Mease P; Krueger GG; Gladman D; Gomez-Reino J; Papp K; Zrubek J; Mudivarthy S; Mack M; Visvanathan S; Beutler A
    Arthritis Rheum; 2009 Apr; 60(4):976-86. PubMed ID: 19333944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke under treatment with ustekinumab for psoriatic arthritis.
    Aboudiab M; Andréjak M; Husein T; Goëb V
    Rev Neurol (Paris); 2019 Apr; 175(4):271-272. PubMed ID: 30638925
    [No Abstract]   [Full Text] [Related]  

  • 6. Golimumab (simponi) for inflammatory arthritis.
    Med Lett Drugs Ther; 2009 Jul; 51(1316):55-6. PubMed ID: 19590489
    [No Abstract]   [Full Text] [Related]  

  • 7. Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.
    Gottlieb A; Menter A; Mendelsohn A; Shen YK; Li S; Guzzo C; Fretzin S; Kunynetz R; Kavanaugh A
    Lancet; 2009 Feb; 373(9664):633-40. PubMed ID: 19217154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE).
    Iannone F; Santo L; Bucci R; Semeraro A; Carlino G; Paoletti F; Quarta L; Leucci P; Zuccaro C; Marsico A; Scioscia C; D'Onofrio F; Mazzotta D; Muratore M; Cantatore FP; Lapadula G
    Clin Rheumatol; 2018 Mar; 37(3):667-675. PubMed ID: 29411182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How effective is ustekinumab in controlling psoriatic arthritis?
    Bonifati C; Graceffa D
    Dermatol Ther; 2016 May; 29(3):155-9. PubMed ID: 26626908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New targets in psoriatic arthritis.
    Braun J
    Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii30-ii37. PubMed ID: 27856658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence.
    Costa L; Perricone C; Chimenti MS; Del Puente A; Caso P; Peluso R; Bottiglieri P; Scarpa R; Caso F
    Drugs R D; 2017 Dec; 17(4):509-522. PubMed ID: 29058302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secukinumab for the maintenance of glucocorticoid-free remission in a patient with giant cell arteritis and psoriatic arthritis.
    Rotar Ž; Tomšic M; Hocevar A
    Rheumatology (Oxford); 2018 May; 57(5):934-936. PubMed ID: 29394408
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy and safety of ustekinumab in psoriatic arthritis after anti-TNFα failure in routine practice].
    Michel M; Reguiai Z; Fauconier M; Brochot P; Eschard JP; Salmon JH
    Therapie; 2016 Jun; 71(3):281-6. PubMed ID: 27235651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinical and Cost Effectiveness of Ustekinumab for the Treatment of Psoriatic Arthritis: A Critique of the Evidence.
    O'Connor J; Rice S; Smith A; Rodgers M; Lopez RR; Craig D; Woolacott N
    Pharmacoeconomics; 2016 Apr; 34(4):337-48. PubMed ID: 26818809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate in psoriatic arthritis.
    Singh YN; Verma KK; Kumar A; Malaviya AN
    J Assoc Physicians India; 1994 Nov; 42(11):860-2. PubMed ID: 7868484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial.
    Kavanaugh A; van der Heijde D; McInnes IB; Mease P; Krueger GG; Gladman DD; Gómez-Reino J; Papp K; Baratelle A; Xu W; Mudivarthy S; Mack M; Rahman MU; Xu Z; Zrubek J; Beutler A
    Arthritis Rheum; 2012 Aug; 64(8):2504-17. PubMed ID: 22378566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with ustekinumab in a Spanish cohort of patients with psoriasis and psoriatic arthritis in daily clinical practice.
    Almirall M; Rodriguez J; Mateo L; Carrascosa JM; Notario J; Gallardo F
    Clin Rheumatol; 2017 Feb; 36(2):439-443. PubMed ID: 27817126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
    Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ustekinumab Improves Paradoxical Enteropathy Associated With Psoriasis Arthritis.
    Urushikubo J; Kawasaki K; Eizuka M; Yanai S; Nakamura S; Sugai T; Matsumoto T
    Inflamm Bowel Dis; 2019 Sep; 25(10):e128-e129. PubMed ID: 31300828
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of psoriasis and psoriatic arthritis.
    Papoutsaki M; Costanzo A
    BioDrugs; 2013 Jan; 27 Suppl 1():3-12. PubMed ID: 23990277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.